ArticleExperimental and therapeutic medicine2026

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3.

Chungmin Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.